Skip to content
Governance Register

← US public companies

Passage BIO, Inc.

SEC CIK 1787297 · PASG · last insider filing 2026-06-29

Directors (from insider filings)

NameCapacity as filedFilings
Gowen Maxine Director filed 2021 - 2026
Kassberg Thomas Richard Director filed 2024 - 2026
Countouriotis Athena Director filed 2020 - 2026
Kapadia Sandip Director filed 2020 - 2026
Porter Derrell Director filed 2021 - 2026
Sondhi Dolan Director filed 2023 - 2026
Chou William Director · President and CEO filed 2022 - 2026
Islam Saqib Director filed 2020 - 2025
Kamarck Michael E. Director filed 2022 - 2023
Woiwode Thomas Director filed 2020 - 2023
Goldsmith Bruce A Director · CEO and President filed 2020 - 2022
Yamada Tadataka Director filed 2020 - 2021
Ratcliffe Liam Director filed 2020 - 2021
Heron Patrick J Director filed 2020 - 2020
Squinto Stephen P Director · Head of Research and Dev filed 2020 - 2020

Officers (from insider filings)

NameTitle as filedFilings
Borthwick Kathleen SVP, Interim CFO filed 2023 - 2026
Cale Edgar B. Interim CEO, GC & Corp. Sec. filed 2020 - 2025
Forman Mark S Chief Medical Officer filed 2022 - 2024
King Simona Chief Financial Officer filed 2021 - 2023
Fotopoulos Alexandros Chief Technical Officer filed 2020 - 2023
Toernsen Monika Maria Chief Commercial Officer filed 2021 - 2022
Salinas Eliseo Oreste Chief Res. & Develop Officer filed 2021 - 2022
Quigley Jill M. Chief Operating Officer filed 2020 - 2021
Burkavage Brian Controller filed 2021 - 2021
Morris Richard Steven Chief Financial Officer filed 2020 - 2021
Romano Gary Chief Medical Officer filed 2020 - 2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.